Big Gain For Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. (ARMP:NYSEMKT) rocketted at $4.85, a gain of 73.8%. The stock got featured on our News Catalysts scanner on Tue 28 Jan 20 at 09:50 AM in the 'RECOMMENDATION' category. From Mon 06 Jan 20, the stock recorded 35.71% Up Days and 13.33% Green Days

The share price of the company has been moving sideways in recent weeks.

About Armata Pharmaceuticals, Inc. (ARMP:NYSEMKT)

Ampliphi Biosciences Corp is a clinical-stage biotechnology company focused on the development of bacteriophage-based therapies for the treatment of antibiotic-resistant bacterial infections. The company is developing phage product candidates using a proprietary discovery and development platform, which is designed for rapid identification, characterization, and manufacturing of multiple phage therapeutics. The lead product candidates are AB-SA01 for the treatment of Staphylococcus aureus infections; and AB-PA01 for the treatment of Paeruginosa infections.